Macquarie Group’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114M | Sell |
1,130,923
-1,231,182
| -52% | -$124M | 0.14% | 193 |
|
|
2025
Q1 | $180M | Buy |
2,362,105
+48,946
| +2% | +$3.73M | 0.22% | 96 |
|
|
2024
Q4 | $160M | Buy |
2,313,159
+27,238
| +1% | +$1.88M | 0.19% | 124 |
|
|
2024
Q3 | $167M | Sell |
2,285,921
-460,707
| -17% | -$33.6M | 0.18% | 137 |
|
|
2024
Q2 | $184M | Sell |
2,746,628
-1,152,876
| -30% | -$77.2M | 0.21% | 110 |
|
|
2024
Q1 | $106M | Sell |
3,899,504
-751,988
| -16% | -$20.4M | 0.12% | 231 |
|
|
2023
Q4 | $144M | Sell |
4,651,492
-2,280
| -0% | -$70.7K | 0.17% | 159 |
|
|
2023
Q3 | $118M | Buy |
4,653,772
+262,692
| +6% | +$6.63M | 0.15% | 186 |
|
|
2023
Q2 | $92.7M | Buy |
4,391,080
+338,716
| +8% | +$7.15M | 0.11% | 253 |
|
|
2023
Q1 | $69.1M | Buy |
4,052,364
+401,559
| +11% | +$6.85M | 0.08% | 321 |
|
|
2022
Q4 | $72.9M | Buy |
3,650,805
+92,881
| +3% | +$1.86M | 0.09% | 326 |
|
|
2022
Q3 | $76.7M | Buy |
3,557,924
+58,914
| +2% | +$1.27M | 0.09% | 293 |
|
|
2022
Q2 | $69M | Buy |
3,499,010
+123,905
| +4% | +$2.44M | 0.08% | 352 |
|
|
2022
Q1 | $79.3K | Buy |
3,375,105
+195,222
| +6% | +$4.59K | 0.06% | 369 |
|
|
2021
Q4 | $86.6M | Sell |
3,179,883
-195,383
| -6% | -$5.32M | 0.07% | 347 |
|
|
2021
Q3 | $93M | Buy |
3,375,266
+185,631
| +6% | +$5.11M | 0.08% | 323 |
|
|
2021
Q2 | $90.8M | Buy |
3,189,635
+2,927,018
| +1,115% | +$83.3M | 0.07% | 330 |
|
|
2021
Q1 | $8.94M | Buy |
262,617
+258,030
| +5,625% | +$8.79M | 0.01% | 742 |
|
|
2020
Q4 | $153K | Hold |
4,587
| – | – | ﹤0.01% | 1753 |
|
|
2020
Q3 | $147K | Hold |
4,587
| – | – | ﹤0.01% | 1683 |
|
|
2020
Q2 | $126K | Buy |
+4,587
| New | +$126K | ﹤0.01% | 1681 |
|
|
2018
Q3 | – | Sell |
-70,000
| Closed | -$1.66M | – | 2209 |
|
|
2018
Q2 | $1.66M | Buy |
+70,000
| New | +$1.66M | ﹤0.01% | 1043 |
|